Vasculitis leucocitoclástica secundaria a vacunación frente a SARS-CoV-2(Pag. e33-e34)
- J.M. Martín Guerra 1
- M. Moreta Rodríguez 1
- 1 Servicio de Medicina Interna, Hospital clínico Universitario de Valladolid, Valladolid, España
ISSN: 1138-3593
Año de publicación: 2022
Número: 5
Páginas: 363-363
Tipo: Artículo
Otras publicaciones en: Semergen: revista española de medicina de familia
Referencias bibliográficas
- J. Tuells, S.M. Ramírez Martín Francisco Xavier Balmis and the vaccine network, a pioneering example of vaccination implementation Salud Publica Mex., 53 (2011), pp. 172-177 View PDFCrossRefView Record in ScopusGoogle Scholar
- M. Voysey, S.A. Costa Clemens, S.A. Madhi, L.Y. Weckx, P.M. Folegatti, P.K. Aley Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Lancet., 397 (2021), pp. 99-111, 10.1016/S0140-6736(20)32661-1 ArticleDownload PDFGoogle Scholar
- S.R. Cohen, L. Prussick, J.S. Kahn, D.X. Gao, A. Radfar, D. Rosmarin Leukocytoclastic vasculitis flare following the COVID-19 vaccine Int J Dermatol., 60 (2021), pp. 1032-1033 View PDFCrossRefView Record in ScopusGoogle Scholar
- M.R. Goeser, V. Laniozs, D.A. Wetter Practical approach to the diagnosis Evaluation, and management of cutaneous smallvessel vasculitis Am J Clin Dermatol., 15 (2014), pp. 299-306 View PDFCrossRefView Record in ScopusGoogle Scholar
- T. Watanabe Vasculitis following influenza vaccination: a review of the literature Curr Rheumatol Rev., 13 (2017), pp. 188-196 View Record in ScopusGoogle Scholar